Dengue Vaccine Appears Successful At Preventing All Four Types Of Disease In Phase 3 Trial.
January 30, 2019
The Wall Street Journal (1/29, Hopkins, McKay, Subscription Publication) reports Takeda Pharmaceutical Co. announced its dengue vaccine TAK-003 was safe and effective in a phase 3 clinical study. Currently, there are currently five dengue vaccine candidat...